1146PDurability of clinical benefit in metastatic epithelial ovarian cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy.
Saved in:
| Title: | 1146PDurability of clinical benefit in metastatic epithelial ovarian cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy. |
|---|---|
| Authors: | Autio, K A1 (AUTHOR), Naing, A2 (AUTHOR), Hung, A3 (AUTHOR), Oft, M4 (AUTHOR), Leveque, J5 (AUTHOR), Falchook, G S6 (AUTHOR) |
| Source: | Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. 1 Chart. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1093/annonc/mdy288.019 |
